Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Nihon Ishigaku Zasshi. [Journal of Japanese History of Medicine]|April 12, 2003
[Acceptance of van Swieten's liquor in Japan]Fumi TakahashiJournal of UOEH|June 22, 2018
Roles of Glycogen Synthase Kinase-3 (GSK-3) in Cardiac Development and Heart DiseaseFumi Takahashi-YanagaBiochemical Pharmacology|May 7, 2013
Activator or inhibitor? GSK-3 as a new drug targetFumi Takahashi-YanagaYakushigaku Zasshi|October 13, 2005
[Fragments of information of Naoe Okamoto - the life of one of Japan's first female pharmacists.]Fumi Takahashi, Keiko KobayashiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Targeting Wnt signaling: can we safely eradicate cancer stem cells?Fumi Takahashi-Yanaga, Michael KahnJournal of Pharmacological Sciences|August 28, 2007
The Wnt/beta-catenin signaling pathway as a target in drug discoveryFumi Takahashi-Yanaga, Toshiyuki SasaguriJournal of Pharmacological Sciences|January 31, 2009
Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugsFumi Takahashi-Yanaga, Toshiyuki SasaguriCellular Signalling|November 21, 2007
GSK-3beta regulates cyclin D1 expression: a new target for chemotherapyFumi Takahashi-Yanaga, Toshiyuki SasaguriBiochemical Pharmacology|March 15, 2018
The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasisShin Ishikane, Fumi Takahashi-YanagaBiochemical Pharmacology|February 19, 2019
Glycogen synthase kinase-3 inhibitor as a multi-targeting anti-rheumatoid drugMasaki Arioka, Fumi Takahashi-YanagaPageof 10